1. Home
  2. HLIT vs CDTX Comparison

HLIT vs CDTX Comparison

Compare HLIT & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HLIT
  • CDTX
  • Stock Information
  • Founded
  • HLIT 1988
  • CDTX 2012
  • Country
  • HLIT United States
  • CDTX United States
  • Employees
  • HLIT N/A
  • CDTX N/A
  • Industry
  • HLIT Radio And Television Broadcasting And Communications Equipment
  • CDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HLIT Technology
  • CDTX Health Care
  • Exchange
  • HLIT Nasdaq
  • CDTX Nasdaq
  • Market Cap
  • HLIT 1.0B
  • CDTX 980.1M
  • IPO Year
  • HLIT 1995
  • CDTX 2015
  • Fundamental
  • Price
  • HLIT $9.81
  • CDTX $46.35
  • Analyst Decision
  • HLIT Buy
  • CDTX Strong Buy
  • Analyst Count
  • HLIT 6
  • CDTX 11
  • Target Price
  • HLIT $12.33
  • CDTX $52.11
  • AVG Volume (30 Days)
  • HLIT 970.6K
  • CDTX 1.3M
  • Earning Date
  • HLIT 07-28-2025
  • CDTX 08-12-2025
  • Dividend Yield
  • HLIT N/A
  • CDTX N/A
  • EPS Growth
  • HLIT N/A
  • CDTX N/A
  • EPS
  • HLIT 0.44
  • CDTX N/A
  • Revenue
  • HLIT $689,797,000.00
  • CDTX $302,000.00
  • Revenue This Year
  • HLIT N/A
  • CDTX N/A
  • Revenue Next Year
  • HLIT $21.63
  • CDTX N/A
  • P/E Ratio
  • HLIT $22.18
  • CDTX N/A
  • Revenue Growth
  • HLIT 20.53
  • CDTX N/A
  • 52 Week Low
  • HLIT $7.91
  • CDTX $10.14
  • 52 Week High
  • HLIT $15.46
  • CDTX $56.83
  • Technical
  • Relative Strength Index (RSI)
  • HLIT 63.20
  • CDTX 77.98
  • Support Level
  • HLIT $9.43
  • CDTX $44.46
  • Resistance Level
  • HLIT $9.95
  • CDTX $50.48
  • Average True Range (ATR)
  • HLIT 0.24
  • CDTX 4.26
  • MACD
  • HLIT 0.09
  • CDTX 1.62
  • Stochastic Oscillator
  • HLIT 89.06
  • CDTX 78.05

About HLIT Harmonic Inc.

Harmonic Inc engaged in broadband access solutions that enable broadband operators to more efficiently and effectively deploy high-speed internet for data, voice, and video services for their customers and versatile and high-performance video delivery software, products, system solutions and services that enable its customers to efficiently create, prepare, store, playout and deliver a full range of high-quality broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smartphones. It has two segments, Broadband which provides broadband access solutions and related services, and Others; and Video business provides video processing and production and playout solutions and services, and Others.

About CDTX Cidara Therapeutics Inc.

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

Share on Social Networks: